BIIB - Biogen Inc
Earnings Results

Biogen Inc ( $BIIB )

Recent earnings result

  1. Biogen EPS beats by $0.68, beats on revenue, boost FY outlook

Events & Presentations

Q1 2020 Earnings Call Webcast

Supporting docs

  1. Listen to webcast
  2. PDF document

Top Stories (BIIB)

Events & Annual meetings

Title Date Webcast
Q1 2020 Earnings Call Webcast Apr 22, 2020 webcast PDF
Q4 and Full Year 2019 Earnings Call Webcast Jan 30, 2020 webcast PDF
Biogen at the 38th Annual J.P. Morgan Healthcare Conference Jan 13, 2020 webcast
Biogen at the 38th Annual J.P. Morgan Healthcare Conference Q & A Session Jan 13, 2020 webcast
Aducanumab Phase 3 Topline Results Dec 5, 2019 webcast PDF

At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies.

Videos about Biogen Inc


The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading